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I. Introduction 
 
a. What is a bioreactor? 
 
Bioreactors have been used for many years in areas other than tissue engineering. They 
have been used in diverse areas such as in fermentation, in water treatment, in food 
processing and in the production of pharmaceuticals [1]. All of these bioreactors are 
devices in which biological or biochemical processes develop under a closely monitored 
and tightly controlled environment. Bioreactors have been used in animal cell culture 
since the 1980s in order to produce vaccines and other drugs and to culture large cell 
populations. Bioreactors for use in tissue engineering have progressed from such devices.  
A tissue engineering bioreactor can be defined as a device that uses mechanical means to 
influence biological processes [2].  In tissue engineering, this generally means that 
bioreactors are used to stimulate cells and encourage them to produce extra-cellular 
matrix (ECM). There are numerous types of bioreactor which can be classified by the 
means they use to stimulate cells.  A number of these will be discussed below.  
 
b. Why are bioreactors needed in tissue engineering? 
 
Tissue engineering technologies are based on the biological triad of cells, signalling 
mechanisms and extracellular matrix. To simulate the development of tissues in vitro, 
tissue engineering aims to optimise cell growth, by providing regulatory signals in the 
form of growth factors and a regeneration template in the form of scaffold.  Bioreactors 
may be used as an alternative to or in conjunction with growth factors in the signalling 
part of the triad.  Defects requiring tissue-engineering solutions are typically many 
millimetres in size [3]. Scaffolds in such a size range are easily fabricated. However, 
problems arise when culturing cells on these scaffolds. Static culture conditions result in 
scaffolds with few cells in the centre of the construct [4]. This heterogeneous cell 
distribution is a major obstacle to developing any three-dimensional tissue or organ in 
vitro.  It has been shown that despite homogeneous cell seeding, after long periods in 
culture, more cells are found on the periphery of demineralised trabecular bone constructs 
[4]. This is due to cell necrosis and cell chemotaxis.  Necrosis occurs at the centre of the 
scaffold due to a lack of nutrient delivery to, and waste removal from that area. The only 
mechanism by which nutrients and waste can move when a scaffold is in static culture is 
by diffusion. As the size of the scaffold increases, diffusion to the centre of the construct 
becomes more difficult. In addition, as cells on the periphery grow and secrete 
extracellular matrix, movement of fluid to the interior of the scaffold is further impeded. 
Chemotaxis of the cells from the interior towards the periphery occurs because of the 
concentration gradient in nutrients that has been set up [3]. Nutrient concentration is 
greater at the periphery so cells move along this gradient towards the periphery in order 
to obtain the nutrients they require. It has been found that mineralised bone matrix 
reaches a maximum penetration depth of 240 µm on poly( DL-lactic-co-glycolic acid) 
scaffolds seeded with stromal osteoblasts, which is far thinner than an ideal bone graft 
replacement [5]. 
 
Figure 5.3.1 shows the distribution of smooth muscle cells in tissue engineered vascular 
tissue. Homogeneous distribution has been achieved by using a bioreactor [6]. In order to 
increase cell viability throughout a scaffold, fluid transport needs to be enhanced. A 
bioreactor may be used to achieve this aim.  In addition to enhancing cell distribution, 
another important aspect of bioreactor use is cell stimulation. Cells respond to 
mechanical stimulation and bioreactors can be used to apply such stimulation. This can 
encourage cells to produce ECM in a shorter time period and in a more homogeneous 
manner than would be the case with static culture. For example, in comparisons between 
ECM protein levels after 5 weeks in culture, scaffolds cultured under hydrostatic pressure 
showed significant improvements over scaffolds cultured in static medium [7].  A benefit 
of ECM production is the increase in mechanical stiffness that it provides to the 
construct. A six-fold increase in equilibrium aggregate modulus (an intrinsic property of 
cartilage which is a measure of stiffness) was found after 28 days of culture in a 
compression bioreactor compared to free swelling controls [8].  
 
Another important application of bioreactors is in cellular differentiation. Mechanical 
stimulation can be used to encourage stem cells down a particular path and hence provide 
the cell phenotype required. Bioreactors can provide biochemical and physical regulatory 
signals that guide differentiation [9]. There is great potential for using mesenchymal stem 
cells and other multipotent cells to generate different cell types and bioreactors can play 
an important role in this process. 
 
c. Bioreactor design requirements 
 
In general, bioreactors are designed to perform at least one of the following five 
functions: 1) providing uniform cell distribution, 2) maintaining the desired concentration 
of gases and nutrients in the medium, 3) providing mass transport to the tissue, 4) 
exposing tissue to physical stimuli, or 5) providing information about the formation of 3D 
tissue [10]. 
 
While the detailed requirements for bioreactor design are tissue- and/or application- 
specific, there are a few general principles which have to be adhered to when developing 
a bioreactor. The material selection is very important as it is vital to ensure that the 
materials used to create the bioreactor do not elicit any adverse reaction from the cultured 
tissue. Any material which is in contact with media must be biocompatible or bioinert. 
This eliminates the use of most metals, although stainless steel can be used if it is treated 
so that chromium ions do not leach out into the medium. Numerous plastics comply with 
this constraint but there are further limitations on material selection that must also be kept 
in mind. Materials must be usable at 37°C in a humid atmosphere. They must be 
sterilisable if they are to be re-used. Bioreactor parts can be sterilised by autoclaving or 
disinfected by submersion in alcohol. If they are to be autoclaved, materials that can 
withstand numerous cycles of high temperature and pressure must be used in bioreactor 
manufacture. Alternatively, some non-sterilisable disposable bioreactor parts may be 
used which can be replaced after each use of the bioreactor. Other material choices are 
between transparent or opaque and flexible or inflexible materials. Materials with 
different properties are needed for various components in the bioreactor. For example, 
transparent materials can be of benefit in allowing the construct to be monitored in the 
bioreactor during culture while flexible tubing can help with assembly of the bioreactor. 
 
The design of the bioreactor should be as simple as possible, avoiding the introduction of, 
for example, machined recesses which could collect condensed steam during autoclaving 
and become breeding grounds for micro-organisms. Simplicity in design should also 
mean that the bioreactor is quick to assemble and disassemble. Apart from being more 
efficient, this ensures that cell-seeded constructs inserted into the bioreactor are out of the 
incubator for the minimum amount of time possible. This minimises the risk to the cells 
and the experiment being undertaken. 
 
The specific application of the bioreactor must be kept in mind during the design process 
to ensure that all the design constraints are met. If various parameters such as pH, 
nutrient concentration or oxygen levels are to be monitored, these sensors should be 
incorporated into the design. If a pump or motor is to be used, it must be small enough to 
fit into an incubator and also be usable at 37°C and in a humid environment. The forces 
needed for cellular stimulation are very small so it is important to ensure that the 
pump/motor has the capability to apply small forces accurately. In any design involving 
fluids, problems can arise with leaking fluid seals and, if possible, the need for seals 
should be removed. However, in most cases, fluid seals are necessary and good design 
should decrease the problems with them. If a prototype bioreactor is being designed, it is 
worthwhile thinking about scale up opportunities for the bioreactor from the outset. This 
may mean designing a device that is relatively easy to enlarge without changing its 
characteristics or designing a simple device of which many more can be made so that 
numerous scaffolds can be cultured at one time. 
 
II. Bioreactors in tissue engineering 
 
a. Spinner flask bioreactor 
 
Continuous stirred-tank reactors are commonly used in bioprocessing, for example in 
solid-state fermentation of organisms such as yeast [11] and spinner flask bioreactors for 
use in tissue engineering progressed from these devices. In a spinner flask (Figure 5.3.2), 
scaffolds are suspended at the end of needles in a flask of culture media. A magnetic 
stirrer mixes the media and the scaffolds are fixed in place with respect to the moving 
fluid. Flow across the surface of the scaffolds results in eddies in the scaffolds' superficial 
pores. Eddies are turbulent instabilities consisting of clumps of fluid particles that have a 
rotational structure superimposed on the mean linear motion of the fluid particles.  They 
are associated with transitional and turbulent flow. It is via these eddies that fluid 
transport to the centre of the scaffold is thought to be enhanced [3]. Typically, spinner 
flasks are around 120 ml in volume (although much larger flasks of up to 8 litres have 
been used), are run at 50-80 rpm and 50% of the medium used in them is changed every 
two days [12]. Cartilage constructs have been grown in spinner flasks to thicknesses of 
0.5 mm [13]. While this is an improvement on cartilage grown in static medium, it is still 
too thin for clinical use. Mass transfer in the flasks is not good enough to deliver 
homogeneous cell distribution throughout scaffolds and cells predominantly reside on the 
construct periphery [3].  
 
b. Rotating wall bioreactor 
 
The rotating wall bioreactor was developed by NASA [14]. It was originally designed 
with a view to protecting cell culture experiments from high forces during space shuttle 
take off and landing. However, the device has proved useful in tissue engineering here on 
earth. In a rotating wall bioreactor (Figure 5.3.3), scaffolds are free to move in media in a 
vessel. The wall of the vessel rotates, providing an upward hydrodynamic drag force that 
balances with the downward gravitational force, resulting in the scaffold remaining 
suspended in the media. Fluid transport is enhanced in a similar fashion to the mechanism 
in spinner flasks and the devices also provide more homogeneous cell distribution than 
static culture [3]. Gas exchange occurs through a gas exchange membrane and the 
bioreactor is rotated at speeds of 15-30 rpm. Cartilage tissue of 5 mm thickness has been 
grown in this type of bioreactor after seven months of culture [15]. As tissue grows in the 
bioreactor, the rotational speed must be increased in order to balance the gravitational 
force and ensure the scaffold remains in suspension.  
 
 
 
 
c. Compression bioreactors 
 
Another widely used type of bioreactor is the compression bioreactor. This class of 
bioreactor is generally used in cartilage engineering and can be designed so that both 
static loading and dynamic loading can be applied. This is because static loading has been 
found to have a negative effect on cartilage formation while dynamic loading, which is 
more representative of physiological loading, has provided better results than many other 
stimuli [16].      
 
In general, compression bioreactors consist of a motor, a system providing linear motion 
and a controlling mechanism. An example of such a system is shown in Figure 5.3.5, 
where a cam-follower system is used to provide displacements of different magnitudes 
and frequencies. A signal generator can be used to control the system and load cells and 
linear variable differential transformers can be used to measure the load response and 
imposed displacement respectively [8, 17]. The load can be transferred to the cell-seeded 
constructs via flat platens which distribute the load evenly, however in a device for 
stimulating multiple scaffolds simultaneously, care must be taken that the constructs are 
of similar height or the compressive strain applied will vary as the scaffold height does.   
Mass transfer is improved in dynamic compression bioreactors over static culture (as 
compression causes fluid flow in the scaffold) and dynamic compression can also 
improve the aggregate modulus of the resulting cartilage tissue to levels approaching 
those of native articular cartilage [8].  
 
 
d. Strain bioreactors 
 
Tensile strain bioreactors have been used in an attempt to engineer a number of different 
types of tissue including tendon, ligament, bone, cartilage and cardiovascular tissue. 
Some designs are very similar to compression bioreactors, only differing in the way the 
force is transferred to the construct. Instead of flat platens as in a compression bioreactor, 
a way of clamping the scaffold into the device is needed so that a tensile force can be 
applied. Tensile strain has been used to differentiate mesechymal stem cells along the 
chondrogenic lineage. A multistation bioreactor was used in which cell-seeded collagen-
glycosaminoglycan scaffolds were clamped and loaded in uniaxial tension [18].   
Alternatively, tensile strain can also be applied to a construct by attaching the construct to 
anchors on a rubber membrane and then deforming the membrane. This system has been 
used in the culture of bioartificial tendons with a resulting increase in Young’s modulus 
over non-loaded controls [19].  
 
e. Hydrostatic pressure bioreactors: 
 
In cartilage tissue engineering, hydrostatic pressure bioreactors can be used to apply 
mechanical stimulus to cell-seeded constructs. Scaffolds are usually cultured statically 
and then moved to a hydrostatic chamber for a specified time for loading. Hydrostatic 
pressure bioreactors consist of a chamber which can withstand the pressures applied and 
a means of applying that pressure (Figure 5.3.6). For example, a media-filled pressure 
chamber can be pressurised using a piston controlled by an actuator [16]. For sterility, the 
piston can apply pressure via an impermeable membrane so that the piston itself does not 
come into contact with the culture media.  Variations on this design include a water-filled 
pressure chamber which pressurises a media-filled chamber via an impermeable film and 
is controlled using a variable backpressure valve and an actuator [20].  
 
f. Flow perfusion bioreactor 
 
Flow perfusion bioreactors generally consist of a pump and a scaffold chamber joined 
together by tubing. A media reservoir may also be present. The scaffold is kept in 
position across the flow path of the device (Figure 5.3.4). Media is perfused through the 
scaffold, thus enhancing fluid transport.   
 
Culture using flow perfusion bioreactors has been shown to provide more homogeneous 
cell distribution throughout scaffolds. Collagen sponges have been seeded with bone 
marrow stromal cells and perfused with flow. This has resulted in greater cellularity 
throughout the scaffold in comparison to static controls, implying that better nutrient 
exchange occurs due to flow [21]. Using a biphasic calcium-phosphate scaffold, abundant 
ECM with nodules of CaP was noted after 19 days in steady flow culture [22].  
 In comparisons between flow perfusion, spinner flask and rotating wall bioreactors, flow 
perfusion bioreactors have proved to be the best for fluid transport. Using the same flow 
rate and the same scaffold type, while cell densities remained the same using all three 
bioreactors, the distribution of the cells changed dramatically depending on which 
bioreactor was used. Histological analysis showed that spinner flask and static culture 
resulted in the majority of viable cells being on the periphery of the scaffold. In contrast, 
the rotating wall vessel and flow perfusion bioreactor culture resulted in uniform cell 
distribution throughout the scaffolds [3, 23]. After 14 days in culture, the perfusion 
bioreactor had higher cell density than all other culture methods [3].  
 
In our laboratory, a flow perfusion bioreactor has been developed to examine the effects 
of different flow profiles on cell-seeded collagen-glycosaminoglycan scaffolds [24]. The 
scaffold chamber was specifically designed to ensure that the compliant scaffold was 
under perfusive flow. This involved using a scaffold of larger diameter than the flow path 
and using spacers to ensure the scaffold was under 10% compression during culture. A 
programmable syringe pump was used in order to stimulate the cell-seeded constructs 
using different flow profiles.  As discussed below, this device demonstrated that 
intermittent flow perfusion is advantageous for mechanically stimulating osteoblasts 
while maintaining cell viability. 
 
g. Combined bioreactors 
 
In addition to the bioreactors mentioned thus far, numerous combinations of the different 
types of bioreactor have been used in order to better mimic the in vivo environment in 
vitro. In most cases, these more complicated bioreactors involve adding a perfusion loop 
on top of a standard bioreactor. Examples include compression, tensile strain or 
hydrostatic bioreactors with added perfusion [7, 20, 25]. These different bioreactors allow 
for nutrient exchange to take place due to perfusion while stimulation occurs due to a 
different mechanical stimulus. Bioreactors for engineering very specialised tissues have 
also been developed. One example of such a bioreactor is a combined tensile and 
vibrational bioreactor for engineering vocal fold tissue [26]. This bioreactor mimics the 
physiological conditions that human vocal folds experience in an attempt to develop the 
tissue in the laboratory (Figure 5.3.7). Vocal fold tissue experiences vibrations of 100-
1000 Hz at an amplitude of approximately 1 mm, which is a unique stimulus in the 
human body [27].  
 
   
III. Tissue formation in bioreactor systems  
 
 
Tissue engineering of all three dimensional tissues require homogeneous cell distribution 
in order for homogeneous tissue to develop. Therefore, there is a need for bioreactor 
culture in numerous different disciplines in tissue engineering. Bioreactor culture has 
been used in a diverse range of applications including skin, bladder and liver tissue 
engineering [1, 28]. Here, the use of bioreactor culture in bone, cartilage and 
cardiovascular tissue engineering will be discussed.  
 
a. Bone 
 
Bone is comprised of a mineral phase, collagen and cells. The mineral phase of bone is a 
hard, brittle material (hydroxyapatite) that is strong in compression but cannot withstand 
large shear or tensile loads. In contrast, collagen fibres are strong in tension and flexible 
in bending but weak in compression. Bone grafts are required to aid bone defect and non-
union healing. The aim in using them is to restore function to the damaged area as 
quickly and completely as possible [29]. They are required in a number of procedures 
including, for example, replacing diseased bone, filling bone voids after non-unions or 
cyst removal, reconstructive surgery and in spinal fusion operations.  The most 
commonly used graft in bone replacement is the autograft. Autografts are grafts taken 
from the patients themselves, usually from the iliac crest, although the distal femur, the 
greater trochanter, and the proximal tibia can also be used [29]. This process is expensive 
and the size of graft that can be obtained is limited. Morbidity of the site the graft is 
acquired from is another problem and complications can arise due to infection and 
chronic pain [29]. An alternative to the autograft is the allograft. The term allograft is 
used for bone grafts which are obtained from an organ donor. A drawback to this option 
is the danger of infection. Xenografts, acquired from animal bone, are another alternative. 
However, the morphology of the bone is different to that of humans and the risk of cross-
species infection exists. Coral has also been used but its structure is very different to that 
of bone and hence osteointegration of this type of graft has proved difficult [30]. 
The use of natural bone grafts has proved problematic and therefore attention has turned 
to tissue engineering. Engineered tissue must be strong enough to allow load bearing after 
implantation. Resorbability of the scaffold is another important issue. Ideally, as the 
scaffold is resorbed, bone should be deposited in its place, thus ensuring no loss in 
mechanical strength. A morphology that allows movement of cells and supports 
vascularisation is important for a scaffold material. A high porosity and controllable pore 
size can provide this. Cells must be able to penetrate into the core of the scaffold so that 
they are homogeneously distributed throughout the graft. There must be space to allow 
for transport of nutrients to and waste removal from cells, so the pores must be 
interconnected [31]. Thus, a balance must be struck between mechanical strength and 
porosity to develop an ideal scaffold for bone tissue engineering. The use of a bioreactor 
with such a scaffold should provide a homogeneous distribution of stimulated cells. 
It has been shown that fluid flow can stimulate bone cells to increase levels of bone 
formation markers [4, 32-37] and its use could improve mineralisation of the scaffold on 
which cells are seeded.  Flow perfusion bioreactors increase alkaline phosphatase (ALP) 
expression after 7 and 14 days more than spinner flasks or rotating wall vessels [3] and 
are more commonly used than any other bioreactor for use in 3-D stimulation studies. In 
one study, MC3T3-E1 cells were seeded on decalcified human trabecular bone, the flow 
rate of perfusion altered and the mRNA expression of Runx2, OC and ALP measured [4]. 
It was found that using a steady flow rate of only 1 mL/min killed nearly all the cells on 
the scaffold after 7 days in culture. However, a flow rate of 0.01 mL/min led to a high 
proportion of viable cells both on the surface and inside the scaffold. This compared 
favourably to static culture, where cells were predominantly on the periphery [4].  
 
Using a CaP scaffold and a flow rate of 0.025 mL/min in a flow perfusion bioreactor, 
PGE2 levels were found to increase over static controls. When a stimulus of 30 minutes 
of oscillatory flow at 1 Hz with a 40 mL/min peak was superimposed on the steady flow, 
PGE2 levels increased further. The number of cells left residing on the scaffolds 
decreased due to this large dynamic stimulus but this decrease was not found to be 
statistically significant [38]. When different flow profiles were used intermittently to 
stimulate cells on a highly porous collagen-glycosaminoglycan scaffold in our laboratory, 
it was found that intermittent flow caused greater stimulation than a continuous low flow 
rate without a loss in cell number [39]. Cyclyoxygenase-2 and osteopontin expression 
increased due to culture in the bioreactor, as did prostaglandin E2 production. This lends 
further backing to the hypothesis that  the combination of a perfusion period (for nutrient 
delivery and waste removal) and a stimulation period may deliver enhanced fluid 
transport with enhanced stimulation of cells and may yet prove to be the optimum regime 
for bioreactor culture of bone cells.  
 
 
b. Cartilage 
 
Cartilage is a supporting tissue containing chondroitin sulphates, collagen and elastic 
fibres and cells. The cells present in cartilage are known as chondrocytes and they are 
situated in lacunae in the cartilage matrix. Cartilage is avascular and nutrient and waste 
product exchange occurs purely by diffusion through the cartilage matrix. When minor 
damage occurs to cartilage, it can repair by appositional growth, but when severe damage 
occurs, the body cannot replace the cartilage [40]. Cartilage tissue engineering may offer 
the solution to this problem. There are three types of cartilage: hyaline cartilage, elastic 
cartilage and fibrocartilage. Joints can contain both hyaline cartilage and fibrocartilage, 
with the more flexible hyaline cartilage covering the bone and the more durable 
fibrocartilage acting as a shock-absorber between bones. As a joint moves, there is 
motion between two articulating layers of cartilage. This deforms the cartilage, causes 
fluid flow within it and induces a hydrostatic pressure load on it. These mechanical forces 
affect the chondrocytes in the cartilage. The force applied, along with the length of time it 
is applied for and the frequency of application modifies the response of chondrocytes 
[41]. This is useful in bioreactor design and for use in cartilage tissue engineering; if the 
correct stimulation pattern is used, chondrocytes can be induced to produce more 
extracellular matrix and this can result in more cartilage-like tissue being formed.       
 
After twenty weeks in static culture, the aggregate modulus of tissue-engineered cartilage 
was 179±9 kPa. This is 40% of the value reported for native cartilage [42]. At twenty five 
weeks, the modulus had not increased further so this may be the closest approximation to 
cartilage that can be cultured without the aid of a bioreactor. The most commonly used 
bioreactors in cartilage tissue engineering are compression bioreactors. When free 
swelling controls were compared to dynamically loaded agarose gels, after 28 days in 
culture, there was a six-fold increase in the equilibrium aggregate modulus for the loaded 
gels [8]. A sinusoidal strain of 10% at 1 Hz was applied to the gels for five days per week 
for a total of three hours per day with a rest period of one hour between each hour of 
loading. This complex loading pattern was deemed to be physiological and it resulted in 
increased glycosaminoglycan content over free swelling controls after 21 days in culture. 
The combination of increased modulus and increased glycosaminoglycan formation over 
free swelling controls after only four weeks in culture demonstrates the benefits of 
bioreactor culture in cartilage tissue engineering. 
 
Compression bioreactors have also been used to examine the effect of loading on the 
differentiation of bone marrow mesenchymal stem cells down the chondrocytic lineage. 
Growth factors such as transforming growth factor (TGF-β) can also be used to 
encourage differentiation. In a study comparing the use of compressive loading, the use 
of TGF-β and the use of a combination of loading and TGF-β, it was found that 
compressive loading alone was just as effective at inducing chondrogenic differentiation 
as TGF-β or TGF-β plus loading [17].  
 
c. Cardiovascular tissue 
 
There are three main types of tissue that are encompassed by the heading cardiovascular 
tissue, namely: vascular, cardiac muscle and heart valve tissue. These different tissues 
experience different mechanical environments in the body and therefore, in tissue 
engineering, they are cultured using different bioreactors and under different loading 
conditions in an attempt to recreate physiological loading conditions in the laboratory.  
 
Vascular tissue 
Blood vessels must be flexible enough to move during physiological activities and yet 
tough enough to withstand the pressure changes that occur as the heart beats. Blood 
vessels consist of three layers of tissue: the tunical intima, the tunica media and the tunica 
externa. The intima (innermost part of the blood vessel) consists of an endothelial lining 
and a layer of connective tissue containing elastic fibres. The media consists of smooth 
muscle tissue and loose connective tissue and in arteries, the externa consists of 
connective tissue and collagen fibres. Arteriosclerosis is associated with half of all deaths 
in the United States each year [40]. It is a thickening and toughening of the arterial walls 
and can lead to coronary heart disease if it occurs in the coronary arteries or stroke if it 
occurs in the arteries supplying the brain with blood. Coronary heart disease can be 
treated by bypass surgery, when a section of artery or vein is removed from elsewhere in 
the body and used to bypass the blockage.  Drawbacks with this procedure are that it 
creates another trauma site in the body and often, sufficient tissue for bypass is not 
available [6]. Research into tissue engineering of vascular tissue is proving promising for 
growing arteries in vitro that may be used instead of the patient’s own blood vessels. 
 
The ideal graft for vascular bypass consists of a confluent endothelium at the lumen and a 
smooth muscle layer surrounding it with sufficient mechanical integrity for suture 
retention and tolerance of arterial pressures. The endothelial layer is important as a 
confluent layer of endothelial cells inhibits the proliferation of smooth muscle cells. The 
smooth muscle cells are therefore more likely to be quiescent and this decreases the risk 
of thrombosis formation and luminal occlusion [6]. In order to recreate the structure of 
blood vessels in vitro, co-cultures of different cell types must be used. Scaffolds can be 
cultured with smooth muscle cells initially and then a layer of endothelial cells can be 
seeded as the culture period nears its end.  
 
The arteries nearest the heart experience the highest pressures and they have resilient 
walls in order to cope with these changing pressures. They are known as elastic arteries 
and their tunica media contains a high proportion of elastic fibres. This enables them to 
expand as the pressure inside the lumen increases and recoil when the pressure decreases, 
thus allowing them to deal with pressure changes but also to damp the pressure 
oscillations to make blood flow continuous rather than oscillatory in nature [40]. It is this 
expansion and recoil of blood vessels that is the inspiration for a number of bioreactors 
for use in vascular tissue engineering.  
 
Some success has been achieved when culturing vascular tissue in both rotating wall 
vessels [13] and biomimetic bioreactors [6, 25]. Biomimetic bioreactors use combinations 
of strain and perfusion to stimulate vascular tissue development. In one such bioreactor, a 
tube of biodegradable polymer was seeded with smooth muscle cells and silicone tubing 
placed through the centre of the tube. The construct was maintained in a bath of stirred 
media and the highly distensible silicone tubing was pulsed at 165 beats per minute so 
that the scaffold experienced 5% radial strain over an eight week culture period [6].  The 
silicone tubing was then removed, an endothelial cell lining applied to the inner layer of 
the construct and culture medium perfused through the centre of the scaffold. This set up 
resulted in vessels with a rupture strength similar to that of native tissue and with a 
morphology that showed migration of smooth muscle cells throughout the construct. In 
contrast, scaffolds kept in static culture over the same culture period showed no migration 
of smooth muscle cells and therefore an inhomogeneous structure. A bioreactor has also 
been designed to apply both radial and axial strain to cell-seeded constructs, to mimic the 
environment in the body more closely [25]. The bioreactor has two perfusion loops that 
feed the internal and external parts of the scaffold.  The internal perfusion can be pulsatile 
in nature and is of variable frequency.  
 
Cardiac muscle tissue 
Cardiac muscle cells are called cardiocytes or cardiomyocytes. They form extensive 
connections with each other and are almost totally dependent on aerobic metabolism for 
energy. When a myocardial infarction (heart attack) occurs, part of the blood supply to 
the heart muscle is blocked and cardiac muscle cells die due to lack of oxygen delivery 
[40].  Cardiac muscle only has a limited ability to regenerate and scar tissue formed may 
create additional problems by constricting other vessels in the damaged region [40, 43]. 
Cardiac muscle tissue engineering is therefore of interest in developing a method for 
myocardial repair. Oxygen delivery to cardiac cells is vital in order that a sufficiently 
thick layer of tissue can be grown in vitro. This means that the use of bioreactors that 
increase oxygen delivery to cells is important in cardiac muscle tissue engineering. The 
ideal tissue-engineered cardiac muscle tissue graft should have a dense, uniform 
distribution of cardiomyocytes, should contract in response to an electrical stimulus and 
have the mechanical integrity to allow implantation [43]. 
 
Polyglycolic acid (PGA) scaffolds have been seeded with cardiomyocytes and cultured in 
spinner flasks and rotating wall bioreactors [44, 45]. In both these culturing systems, a 
peripheral region densely populated with cells and a central region with a sparse 
population of cells was apparent. Spontaneous contractions of the tissue occurred during 
culture using the spinner flask and impulse propagation occurred due to electrical 
stimulation, but only in the peripheral region [44]. Use of a perfusion system, however, 
delivered a much more uniform distribution of cells with higher cell number on perfused 
scaffolds than scaffolds cultured in an orbitally mixed dish at all time points up to 7 days 
[43]. Spontaneous contractions were also observed in the perfusion system but only up to 
5 days after seeding. Perfused scaffolds contracted synchronously and at constant 
frequency upon electrical stimulation after seven days, while dish-cultured scaffolds 
exhibited an arrhythmic contraction pattern [43].  
 
Heart valves 
There are four valves in the heart that prevent backflow of blood from the ventricles to 
the atria or from the pulmonary trunk and aorta into the ventricles. Problems with these 
valves decrease the heart’s ability to maintain circulatory flow [40]. In severe cases, 
valve replacement is the only option. However, thromboembolism is a substantial risk 
when mechanical valves are used to replace native valves and xenografts or other non-
viable tissue-based grafts often fail due to calcification [46, 47]. Patients with congenital 
malformations of the valves often require a durable replacement that can grow as the 
patient does, and a tissue-engineered valve may therefore be the best option.  
 
Heart valves experience a complex mechanical environment including high bending 
stress and high shear stress in vivo [10]. When grown in static culture, valve leaflets are 
fragile, have a rough surface and a low suture retention strength. In bioreactor culture 
under pulsatile flow, however, leaflets that are intact, mobile, pliable, competent during 
closure and have a tensile strength greater than that of native tissue are formed after 14 
days [46].  In this case, the pulse was applied to the scaffolds by pumping air into a 
chamber connected to the scaffold chamber via a silicone diaphragm. Scaffolds were 
seeded with myofibroblasts initially and after a four day culture period, with endothelial 
cells. The pressure at which the pulse was applied was increased over time, as was the 
flow rate of the media. Thus, as the scaffold became stronger, the forces applied to it 
were increased. The resulting valve leaflets were implanted into lambs and there was no 
evidence of thrombus formation up to 20 weeks after valve replacement. There was some 
evidence of pulmonary regurgitation at 16 and 20 weeks, however. Optimisation of many 
aspects of the culturing process remains to be completed but bioreactor culture of valve 
leaflets has enabled a functioning heart valve to be developed in vitro [46].   
 
   
IV. Bioreactors: state of the art and future directions 
 
The use of bioreactors has brought us a step closer to engineering numerous tissue types 
in the laboratory. At present, most bioreactors are specialised devices with low volume 
output. Their assembly is often time consuming and labour intensive. Many also exhibit 
operator dependent variability. While scaled-up versions of some devices may be useful 
for developing larger amounts of tissue, problems with process consistency and process 
contamination may persist. A better understanding of the different effects of mechanical 
stimulation on cell signalling and mechanotransduction is also needed. This can be 
achieved through the use of existing simple bioreactors in conjunction with numerical 
simulation of culture conditions to minimise the number of experiments needed.   
 
In the future, ways of minimising the time and effort needed in order to form tissue must 
be found if costs are to be minimised and the use of engineered tissue is to become 
routine clinically. One way to do this is to automate the process. The ideal bioreactor 
would need autologous material and a scaffold as inputs and, after a defined culture 
period, would output the required amount of the required tissue. Automated systems for 
culturing cells already exist and work has begun on extending them to incorporate 
mechanical stimulation into the culturing process. Aastrom has developed a system that 
takes bone marrow as an input and expands the stem and progenitor cell population. The 
Automation Partnership has numerous systems for expanding cells. If systems such as 
these are used in conjunction with monitoring systems and a feedback loop, so that 
factors such as the temperature, oxygen level and pH can be regulated, cell culture can be 
optimised. Closed bioreactor systems for seeding and culturing skin grafts under 
perfusion were developed by Advanced Tissue Sciences before the company’s liquidation 
in 2002. As this system demonstrated, the technology exists to enable the incorporation 
of mechanical stimulus into an automated cell culture system and this may be the future 
for bioreactors in tissue engineering.  
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Figure 5.3.1. Histological sections of tissue engineered vascular tissue cultured using a 
bioreactor (on left) and statically (on right). Sections stained with Verhoff’s elastin 
stain. (Niklason et al., 1999) 
Figure 5.3.2. A spinner flask bioreactor. Scaffolds are suspended in medium and the 
medium stirred using a magnetic stirrer to improve nutrient delivery to the scaffold 
(Kim et al., 2005) 
Figure 5.3.3. A rotating wall vessel bioreactor. Scaffolds are suspended in medium due to 
opposing gravitational and drag forces 
(www.che.msstate.edu/research/MDERL/demos/DEMoBioRctrExperiment_files/imag
e002.jpg) 
Figure 5.3.4. A flow perfusion bioreactor (A). Media is forced through the scaffold in the 
scaffold chamber (B) by the syringe pump (Jaasma et al., 2008) 
Figure 5.3.5. A compression bioreactor. Constructs are housed in a petri dish and 
subjected to compressive forces exerted on them via a cam and follower mechanism 
(Mauck et al., 2000) 
Figure 5.3.6 A hydrostatic pressure bioreactor. Constructs are placed in a chamber which 
is subsequently pressurised to the required level (Darling et al., 2003) 
Figure 5.3.7 A bioreactor for vocal fold tissue engineering. Constructs can be stimulated 
using both tensile and vibrational forces (Titze et al., 2004) 
Figure 5.3.8 Structure of an artery. The three layers of the tissue (the tunical intima, the 
tunica media and the tunica externa) can be clearly seen (Martini, 2006)   
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